Heineken document reveals worries over weight-loss drugs and beer sales
Oct 22, 2026
Heineken warns UK venues that surging GLP-1 weight-loss drug usage threatens beer sales due to reduced cravings. Market data confirms users spend less on alcohol, prompting brewers to adapt portfolios with low-alcohol options.